Long-term Jivi Continues to Safely Prevent Bleeds in Severe Hemophilia A

Long-term Jivi Continues to Safely Prevent Bleeds in Severe Hemophilia A

291596

Long-term Jivi Continues to Safely Prevent Bleeds in Severe Hemophilia A

Long-term treatment with Jivi safely and effectively reduced the number of bleeding episodes in adolescents and adults with severe hemophilia A, according to up to seven years of data from the Phase 2/3 PROTECT VIII trial and its extension study. The new data confirmed the previous findings from the main study, which showed that long-term therapy with the Bayer medication was effective at preventing bleeds — even when given at extended intervals up to once…

You must be logged in to read/download the full post.